[1] S. Mitragotri and J. Lahann, "Materials for drug delivery: innovative solutions to address complex biological hurdles," 2012.
[2] K. J. Widder, A. E. Senyei, and D. F. Ranney, "In vitro release of biologically active adriamycin by magnetically responsive albumin microspheres," Cancer research, vol. 40, no. 10, pp. 3512-3517, 1980.
[3] B. Shapiro, "Towards dynamic control of magnetic fields to focus magnetic carriers to targets deep inside the body," Journal of magnetism and magnetic materials, vol. 321, no. 10, pp. 1594-1599, 2009.
[4] A. S. Lübbe et al., "Clinical experiences with magnetic drug targeting: a phase I study with 4′-epidoxorubicin in 14 patients with advanced solid tumors," Cancer research, vol. 56, no. 20, pp. 4686-4693, 1996.
[5] M. W. Wilson et al., "Hepatocellular carcinoma: regional therapy with a magnetic targeted carrier bound to doxorubicin in a dual MR imaging/conventional angiography suite—initial experience with four patients," Radiology, vol. 230, no. 1, pp. 287-293, 2004.
[6] S. Goodwin, C. Peterson, C. Hoh, and C. Bittner, "Targeting and retention of magnetic targeted carriers (MTCs) enhancing intra-arterial chemotherapy," Journal of magnetism and magnetic materials, vol. 194, no. 1-3, pp. 132-139, 1999.
[7] M. G. Krukemeyer, V. Krenn, M. Jakobs, and W. Wagner, "Mitoxantrone-iron oxide biodistribution in blood, tumor, spleen, and liver—magnetic nanoparticles in cancer treatment," Journal of Surgical Research, vol. 175, no. 1, pp. 35-43, 2012.
[8] O. A. Mayorova et al., "Endovascular addressing improves the effectiveness of magnetic targeting of drug carrier. Comparison with the conventional administration method," Nanomedicine: Nanotechnology, Biology and Medicine, vol. 28, p. 102184, 2020.
[9] M. Shamsi, A. Sedaghatkish, M. Dejam, M. Saghafian, M. Mohammadi, and A. Sanati-Nezhad, "Magnetically assisted intraperitoneal drug delivery for cancer chemotherapy," Drug delivery, vol. 25, no. 1, pp. 846-861, 2018.
[10] P. M. Price, W. E. Mahmoud, A. A. Al-Ghamdi, and L. M. Bronstein, "Magnetic drug delivery: where the field is going," Frontiers in chemistry, vol. 6, p. 619, 2018.
[11] B. Shapiro, S. Kulkarni, A. Nacev, S. Muro, P. Y. Stepanov, and I. N. Weinberg, "Open challenges in magnetic drug targeting," Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology, vol. 7, no. 3, pp. 446-457, 2015.
[12] Y.-L. Liu, D. Chen, P. Shang, and D.-C. Yin, "A review of magnet systems for targeted drug delivery," Journal of Controlled Release, vol. 302, pp. 90-104, 2019.
[13] 張維軒, "以高溫超導塊材擄獲磁場進行磁粒子軌跡計算及觀測研究," 2020.
[14] C.-M. Yang, W.-H. Chang, J.-R. Huang, and I.-G. Chen, "Simulation and observation of magnetic particles captured in fluids using high temperature superconductor bulk," IEEE Transactions on Applied Superconductivity, vol. 31, no. 5, pp. 1-4, 2021.
[15] L. C. Barnsley, D. Carugo, M. Aron, and E. Stride, "Understanding the dynamics of superparamagnetic particles under the influence of high field gradient arrays," Physics in Medicine & Biology, vol. 62, no. 6, p. 2333, 2017.
[16] H. Kee, H. Lee, and S. Park, "Optimized Halbach array for focused magnetic drug targeting," Journal of Magnetism and Magnetic Materials, vol. 514, p. 167180, 2020.
[17] A. K. Hoshiar, T.-A. Le, F. U. Amin, M. O. Kim, and J. Yoon, "Studies of aggregated nanoparticles steering during magnetic-guided drug delivery in the blood vessels," Journal of Magnetism and Magnetic Materials, vol. 427, pp. 181-187, 2017.
[18] F. Mishima, Y. Akiyama, and S. Nishijima, "A study on accumulation of magnetic drug in the capillary vessel of target organ using superconducting MDDS," Physica C: Superconductivity and its applications, vol. 470, no. 20, pp. 1837-1840, 2010.
[19] K. Nakagawa, F. Mishima, Y. Akiyama, and S. Nishijima, "Study on magnetic drug delivery system using HTS bulk magnet," IEEE transactions on applied superconductivity, vol. 22, no. 3, pp. 4903804-4903804, 2011.
[20] I. G. Chen, J. Liu, R. Weinstein, and K. Lau, "Characterization of YBa2Cu3O7, including critical current density J c, by trapped magnetic field," Journal of applied physics, vol. 72, no. 3, pp. 1013-1020, 1992.
[21] M. Jalaal, D. Ganji, and G. Ahmadi, "Analytical investigation on acceleration motion of a vertically falling spherical particle in incompressible Newtonian media," Advanced Powder Technology, vol. 21, no. 3, pp. 298-304, 2010.
[22] J. Ferreira, M. Duarte Naia, and R. Chhabra, "An analytical study of the transient motion of a dense rigid sphere in an incompressible Newtonian fluid," Chemical Engineering Communications, vol. 168, no. 1, pp. 45-58, 1998.
[23] Y. Yan, Y. Ma, and J. Liu, "Analysis and correction of the magnetometer’s position error in a cross-shaped magnetic tensor gradiometer," Sensors, vol. 20, no. 5, p. 1290, 2020.
[24] X. Han, Q. Cao, and L. Li, "Design and evaluation of three-dimensional electromagnetic guide system for magnetic drug delivery," IEEE transactions on applied superconductivity, vol. 22, no. 3, pp. 4401404-4401404, 2011.
[25] D. Zhi, T. Yang, J. Yang, S. Fu, and S. Zhang, "Targeting strategies for superparamagnetic iron oxide nanoparticles in cancer therapy," Acta biomaterialia, vol. 102, pp. 13-34, 2020.
[26] J.-H. Lee, J.-w. Kim, and J. Cheon, "Magnetic nanoparticles for multi-imaging and drug delivery," Molecules and cells, vol. 35, no. 4, pp. 274-284, 2013.
[27] A. Z. Wilczewska, K. Niemirowicz, K. H. Markiewicz, and H. Car, "Nanoparticles as drug delivery systems," Pharmacological reports, vol. 64, no. 5, pp. 1020-1037, 2012.
[28] C. Janko et al., "Functionalized superparamagnetic iron oxide nanoparticles (SPIONs) as platform for the targeted multimodal tumor therapy," Frontiers in oncology, vol. 9, p. 59, 2019.
[29] S. O. Aisida, P. A. Akpa, I. Ahmad, T.-k. Zhao, M. Maaza, and F. I. Ezema, "Bio-inspired encapsulation and functionalization of iron oxide nanoparticles for biomedical applications," European polymer journal, vol. 122, p. 109371, 2020.
[30] K. Ulbrich, K. Hola, V. Subr, A. Bakandritsos, J. Tucek, and R. Zboril, "Targeted drug delivery with polymers and magnetic nanoparticles: covalent and noncovalent approaches, release control, and clinical studies," Chemical reviews, vol. 116, no. 9, pp. 5338-5431, 2016.
[31] J.-R. Huang, C.-M. Yang, W.-H. Chang, and I.-G. Chen, "Simulation of Particle Trajectory Under Laminar Flow for MDDS Application," IEEE Transactions on Applied Superconductivity, vol. 32, no. 6, pp. 1-5, 2022.
[32] M. K. Manshadi et al., "Delivery of magnetic micro/nanoparticles and magnetic-based drug/cargo into arterial flow for targeted therapy," Drug delivery, vol. 25, no. 1, pp. 1963-1973, 2018.
[33] M. Klarhöfer, B. Csapo, C. Balassy, J. Szeles, and E. Moser, "High‐resolution blood flow velocity measurements in the human finger," Magnetic Resonance in Medicine: An Official Journal of the International Society for Magnetic Resonance in Medicine, vol. 45, no. 4, pp. 716-719, 2001.
[34] S. Sharma, V. Katiyar, and U. Singh, "Mathematical modelling for trajectories of magnetic nanoparticles in a blood vessel under magnetic field," Journal of Magnetism and Magnetic Materials, vol. 379, pp. 102-107, 2015.
[35] V. R. N. Telis, J. Telis-Romero, H. Mazzotti, and A. L. Gabas, "Viscosity of aqueous carbohydrate solutions at different temperatures and concentrations," International Journal of food properties, vol. 10, no. 1, pp. 185-195, 2007.
[36] M. Tomita and M. Murakami, "Effect of resin layer on the thermal stress of bulk superconductors," Physica C: Superconductivity, vol. 392, pp. 493-498, 2003.